Applications of pulsed ultrafiltration-mass spectrometry

Mass Spectrometry Reviews

Volumn 21, Issue 2, 2002, Pages 76-86

  Johnson, Benjamin M ^a   Nikolic, Dejan ^a   Van Breemen, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Drug development; High throughput screening; Ligand receptor binding; Pulsed ultrafiltration mass spectrometry

Indexed keywords

DRUG PRODUCTS; MACROMOLECULES; SYNTHESIS (CHEMICAL); THERMODYNAMIC PROPERTIES; TOXICITY; ULTRAFILTRATION;

ELECTROPHILIC METABOLITES; PULSED ULTRAFILTRATION-MASS SPECTROMETRY (PUF-MS);

MASS SPECTROMETRY;

DRUG; LIGAND;

ANIMAL; COMBINATORIAL CHEMISTRY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; REVIEW; ULTRAFILTRATION;

ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; LIGANDS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; ULTRAFILTRATION;

EID: 0036489425     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.10020     Document Type: Article

References (31)

1. Beverly M.B., West P., Julian R.K. 2002. Evaluation of a micro volume pulsed ultrafiltration cell for screening ligands in non-covalent complexes. Comb Chem High Throughput Screen 5:73-81.
2. Caldwell G.W., Masucci J.A., Chacon E. 1999. High throughput liquid chromatography-mass spectrometry assessment of the metabolic activity of commercially available hepatocytes from 96-well plates. Comb Chem High Throughput Screen 2:39-51.
3. Chen C.-J., Chen S., Woodbury C.P., Venton D.L. 1998. Pulsed ultrafiltration characterization of binding I. A new method. Anal Biochem 261:164-182.
4. Fosslien E. 2000. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Critical Rev Clinical Lab Sci 37:431-502.
5. Gangjee A., Vasudevan A., Queener S.F. 1997. Conformationally restricted analogues of trimethoprim: 2,6-Diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii. J Med Chem 40:3032-3039.
6. Gu C., Nikolic D., Lai J., Xu X., van Breemen R.B. 1999. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry. Comb Chem High Throughput Screen 2:353-359.
7. Johnson B.M., Bolton J.L., van Breemen R.B. 2001. Screening botanical extracts for quinoid metabolites. Chem Res Toxicol 14:1546-1551.
8. Kuhnz W., Gieschen H. 1998. Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro. Drug Metab Dispos 26:1120-1127.
9. Liu J., Burdette J.E., Xu H., Gu C., van Breemen R.B., Brat K.P.L., Booth N., Constantinou A.l., Pezzuto J.M., Fong H.H.S., Farnsworth N.R., Bolton J.L. 2001. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49:2472-2479.
10. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., Edwards D.A., Flickinger A.G., Moore R.J., Seibert K. 2000. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306-1311.
11. Maurel P. 1996. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Delivery Rev 22:105-132.
12. Meier J. 1982. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents. Am Heart J 104: 364-373.
13. NAPRALERT. A database on natural products. Available on-line through the Scientific and Technical Services of Chemical Abstracts Services, Columbus, Ohio.
14. Needleman P., Isakson P.C. 1997. The discovery and function of COX-2. J Rheumatol 24:6-8.
15. Nikolic D., van Breemen R.B. 1998. Screening for inhibitors of dihydrofolate reductase using pulsed ultrafiltration-mass spectrometry. Comb Chem High Throughput Screen 1:47-55.
16. Nikolic D., Fan P.W., Bolton J.L., van Breemen R.B. 1999. Screening for xenobiotic electrophilic metabolites using pulsed ultrafiltration-mass spectrometry. Comb Chem High Throughput Screen 2:165-175.
17. Nikolic D., Habibi-Goudarzi S., Corley D.G., Garner S., Pezzuto J.M., van Breemen R.B. 2000. Evaluation of cyclooxygenase-2 inhibitors using pulsed ultrafiltration-mass spectrometry. Anal Chem 72:3853-3859.
18. Onorato J., Henion J.D. 2001. Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction. Anal Chem 73:4704-4710.
19. Parkinson A. 1996. An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials. Toxicol Pathol 24:45-57.
20. Reddy B.S., Rao C.V., Seibert K. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566-4569.
21. Robson C., Meek M.A., Grunwaldt J.-D., Lambert P.A., Queener S.F., Schmidt D., Griffin R.J. 1997. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: Activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents. J Med Chem 40: 3040-3048.
22. Rodrigues A.D. 1997. Preclinical drug metabolism in the age of high-throughput screening: An industrial perspective. Pharm Res 14:1504-1510.
23. Shin Y.G., Bolton J.L., van Breemen R.B. 2002. Screening drugs for metabolic stability using pulsed ultrafiltration-mass spectrometry. Comb Chem High Throughput Screen 5:49-54.
24. Shin Y.G., van Breemen R.B. 2001. Analysis and screening of combinatorial libraries using mass spectrometry. Biopharm Drug Dispos 22:353-372.
25. van Breemen R.B., Nikolic D., Bolton J.L. 1998. Metabolic screening using on-line ultrafiltration mass spectrometry. Drug Metab Dispos 26:85-90.
26. van Breemen R.B., Woodbury C.P., Venton D.L. 1998. Screening molecular diversity using mass spectrometry. In: Larsen B.S., McEwen C.N., editors. Mass Spectrometry of Biological Materials. New York: Marcel Dekker; pp 99-113.
27. van Breemen R.B., Huang C.-R., Nikolic D., Woodbury C.P., Zhao Y.-Z., Venton D.L. 1997. Pulsed ultrafiltration-mass spectrometry: A new method for screening combinatorial libraries. Anal Chem 69:2159-2164.
28. Walker D.K., Humphrey M.J., Smith D.A. 1994. Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine. Xenobiotica 24:243-250.
29. Wieboldt R., Zweigenbaum J., Henion J. 1997. Immunoaffinity ultrafiltration with ion spray HPLC/MS for screening smallmolecule libraries. Anal Chem 69:1683-1691.
30. Woodbury C.P., Venton D.L. 1999. Methods of screening combinatorial libraries using immobilized or restrained receptors. Chromatogr B 725:113-137.
31. Zhao Y.-Z., van Breemen R.B., Nikolic D., Huang C.-R., Woodbury C.P., Schilling A., Venton D.L. 1997. Screening solution-phase combinatorial libraries using pulsed ultrafiltration electrospray mass spectrometry. J Med Chem 40:4006-4012.